Hints and tips:
...“2012 is off to a good start for Teva,” said Shlomo Yanai, who has run the company for the past five years....
...Phillip Frost, Teva’s chairman, said in a statement: “Shlomo Yanai … has built a strong foundation for the company’s future. We wish him the best in his new endeavours.”...
...The chief executive of Teva Pharmaceutical Industries Ltd, Shlomo Yanai, is set to retire in May, the WSJ reports....
...So investors welcomed the news that chief executive Shlomo Yanai will retire in May and be replaced by Jeremy Levin, head of strategy, mergers and alliances at Bristol-Myers Squibb....
...Among them is Shlomo Yanai, who stepped down as chief executive of Teva, the Israeli pharmaceuticals group, last week, announcing that he wanted to devote more time to “public service”....
...Shlomo Yanai, Teva’s president and chief executive, said: “This acquisition will enable Teva to deliver on our strategic objective of becoming a leading player in the fast-growing Japanese generics market...
...“This is transforming for Teva’s branded business, as it will help us to deliver on our strategic goal of creating a diversified, multifaceted company,” said Shlomo Yanai, chief executive of Teva....
...Shlomo Yanai, the company’s chief executive and a former Israeli army general, said during a conference call with analysts: “We had an excellent start to the year … and we expect the second part of the year...
...Shlomo Yanai, Teva chief executive, said Ratiopharm aimed to snatch back from Sandoz-owned Hexal the crown as market leader in Germany, the second largest generic drug market....
...Shlomo Yanai, the president and chief executive, said: ”We feel very good....
...But Shlomo Yanai, the 32-year veteran of the Israeli defence forces appointed to lead the company in March last year, has found the conditions no hindrance to corporate expansion....
...Shlomo Yanai, chief executive, told the Financial Times that capitalising on Japan’s small but fast-growing market for generic medicines was a top priority, even just after concluding the $7.5bn acquisition...
...Shlomo Yanai, who took over as chief executive of Teva less than 18 months ago, said of the Barr offer: “This is a transaction in which two great, strong companies are joining forces to capture an even greater...
...From his headquarters just outside Tel Aviv, Shlomo Yanai, a former top general in the Israeli Defence Force, is plotting the next stage in his commercial career: a campaign to reinforce his company Teva...
International Edition